India Pediatric Drugs and Vaccines Market: Safeguarding the Next Generation
India’s pediatric healthcare ecosystem is evolving rapidly through innovation, access, and policy reform. The India Pediatric Drugs and Vaccines Market is currently valued at USD 5.4 billion (2024) and is projected to reach USD 9.2 billion by 2030 , registering a CAGR of nearly 9% . This growth is supported by India’s massive pediatric population—over 430 million children —and expanding vaccination coverage under the Universal Immunization Programme (UIP) . According to Ken Research , increasing R&D spending and clinical advancements in pediatric formulations are transforming India into a key hub for child healthcare innovation. Immunization Growth Strengthens Pediatric Vaccine Penetration India’s strong public immunization network continues to enhance disease prevention and child survival rates. Government initiatives such as Mission Indradhanush and the National Immunization Schedule now cover more than 95% of children under five years of age in several stat...